Health Care Equipment · 19 names · 2026Q2

AI is everywhere. Moats are not.

The investment question is not who is using AI. It is who is turning it into a durable operating advantage.

We look for public companies moving beyond pilots, press releases, and productivity tools — embedding intelligence into the live business in ways that can improve economics, strengthen competitive position, and compound over time.

This is not a thesis on the entire company. It is one lens, examined deliberately on its own: who is building an AI advantage that could matter to shareholders — and who is falling behind?

Our universe starts with the S&P 1500. Our product is the short list: the diamond, or the evolving name, that could break out.